Literature DB >> 17010930

Study of calix[4]resorcinarene-dopamine complexation in mixed phospholipid monolayers formed at the air-water interface.

P Vitovic1, D P Nikolelis, T Hianik.   

Abstract

We have studied the physical properties of monolayers formed by calix[4]resorcinarene and in mixtures with dipalmitoyl phosphatidylcholine (DPPC) in various molar ratios formed at the air-water interface and at presence of dopamine in water subphase by means of measurements of surface pressure and dipole potential. We showed that both calix[4]resorcinarene as well as its mixture with DPPC form stable monolayers at the water subphase. The presence of dopamine resulted in an increase of the mean molecular area and in a decrease of the compressibility modulus of the monolayers. For mixed monolayers at higher content of calix[4]resorcinarene (> 0.2 molar fraction) a deviation from ideal miscibility took place especially for monolayers in a solid state. This can be connected with formation of aggregates of calix[4] resorcinarene. Lowest miscibility and weakest interaction of dopamine with a monolayer was observed for calix[4]resorcinarene molar fraction of 0.33 in the monolayer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010930     DOI: 10.1016/j.bbamem.2006.08.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Monogalactosyldiacylglycerol and digalactosyldiacylglycerol role, physical states, applications and biomimetic monolayer films.

Authors:  Javier Hoyo; Ester Guaus; Juan Torrent-Burgués
Journal:  Eur Phys J E Soft Matter       Date:  2016-03-29       Impact factor: 1.890

2.  Comparing experimental and simulated pressure-area isotherms for DPPC.

Authors:  Susan L Duncan; Ronald G Larson
Journal:  Biophys J       Date:  2008-01-16       Impact factor: 4.033

3.  Interaction of Silver-Lignin Nanoparticles With Mammalian Mimetic Membranes.

Authors:  Javier Hoyo; Kristina Ivanova; Juan Torrent-Burgues; Tzanko Tzanov
Journal:  Front Bioeng Biotechnol       Date:  2020-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.